Parkinson's Disease Trial, Not Yet Recruiting NCT06963918 Sponsor: General University Hospital, Prague Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT06963918
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's Disease
  • People who are 18 years of age or older
  • People who score 19 or above on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
  • People who have an abnormal forward bending of the upper or lower back while standing and walking, which fully corrects itself when lying flat on their back

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who experience severe involuntary movements or unpredictable "on-off" episodes related to their Parkinson's Disease
  • People whose Parkinson's Disease medication has been changed in the 3 months before joining the trial
  • People who have had major spine surgery or have a significant spine or musculoskeletal condition
  • People who need support equipment (such as a frame or rail) to stand up from a chair or bed
  • People who have other neurological, bone and joint, or heart and circulation conditions that could affect their balance or posture
  • People who are unable to fully close their lips (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +420 224 965 513

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
General University Hospital, Prague
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 November 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Change in the forward trunk flexion (FTF) angle

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov